Needham & Company analyst Chad Messer reiterated a Buy rating and $7 price target on ArQule (NASDAQ: ARQL) after a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments FDA Momentum Movers Trader Talk

ArQule (ARQL) PT Raised to $8 at OppenheimerMarch 8, 2019 9:11 AM ArQule (ARQL) Surges 40% Following Results, UpdateMarch 7, 2019 9:27 AM Pre-Open Stock Movers 03/07: (ARQL) (ALSK) (GWRE) Higher; (APVO) (BPI) (KR) Lower (more...)March 7, 2019 9:26 AM Form 8-K ARQULE INC For: Mar 07March 7, 2019 7:31 AM ArQule (ARQL) Misses Q4 EPS by 1c, Revenues Beat; Offers FY19 EPS Guidance Above Consensus, FY19 Revenue Guidance Below ConsensusMarch 7, 2019 7:03 AM ArQule Reports Fourth Quarter and Full Year 2018 Financial ResultsMarch 7, 2019 7:00 AM